You are a Nursing Teacher and Exam Expert. Create simple, clear, deep, exam-ready notes for the topic I give. Rules: - Use very simple English and short sentences. - Explain the topic deeply so no important textbook concept is missed. - Use bullet points, flowcharts (β†’), tables, and simple labeled diagrams/pictures when useful. - Explain difficult words in brackets. Structure: 1. Introduction 2. Definition 3. Types / Classification 4. Causes / Etiology 5. Pathophysiology (flowchart) 6. Signs & Symptoms 7. Diagnosis / Investigations 8. Management - Medical - Nursing care (detailed) 9. Complications 10. Prevention 11. Quick revision points Add if needed: - Microbiology β†’ structure, classification, culture, lab diagnosis - Pharmacology β†’ classification, mechanism, uses, side effects, nursing responsibilities Also include: - 1–2 short clinical examples - Mnemonics if useful - 5 long questions, 5 short questions, 10 very short, 10 MCQs - Answer key - A final 1-page quick revision summary Wait for my topic. Unit IV: Explain the concepts of immunity, hyper sensitivity and immunization Β· Immunity Β· Immunity: Types, classification Β· Antigen and antibody reaction Β· Hypersensitivity reactions Β· Serological tests Β· Immunoglobulins: Structure, types & properties Β· Vaccines: Types & classification, storage and handling, cold chain, Immunization for various diseases Β· Immunization Schedule

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching Images

immunoglobulin structure IgG antibody diagram

Searching Images

hypersensitivity types Gell Coombs classification reactions

Now I have all the material I need. Let me compose the comprehensive nursing exam notes.

πŸ“š UNIT IV: IMMUNITY, HYPERSENSITIVITY & IMMUNIZATION

Complete Nursing Exam-Ready Notes


1. INTRODUCTION

  • The human body is constantly exposed to harmful microorganisms (bacteria, viruses, fungi, parasites).
  • The body has a defense system called the immune system to fight these threats.
  • This unit covers how immunity works, what happens when it overreacts (hypersensitivity), and how we use vaccines to protect people.

2. DEFINITION

TermDefinition
ImmunityThe body's ability to resist infection and disease caused by foreign substances
AntigenAny foreign substance that triggers an immune response (e.g., bacteria, virus, pollen)
AntibodyA protective protein made by B cells in response to an antigen
ImmunizationThe process of making a person immune to a disease, usually by a vaccine
HypersensitivityAn exaggerated immune response that damages the body's own tissues

3. TYPES / CLASSIFICATION OF IMMUNITY

A. Basic Classification

IMMUNITY
β”œβ”€β”€ INNATE (Natural / Non-Specific)
β”‚   β”œβ”€β”€ Present from birth
β”‚   β”œβ”€β”€ No memory
β”‚   └── First line of defense
└── ADAPTIVE (Acquired / Specific)
    β”œβ”€β”€ Develops after exposure
    β”œβ”€β”€ Has MEMORY
    └── Specific to each antigen

B. Innate Immunity β€” Details

ComponentFunction
Skin & mucus membranesPhysical barrier
Stomach acid (pH 2)Kills pathogens
FeverSlows pathogen growth
InflammationBrings WBCs to site of infection
NK cells (Natural Killer cells)Kill virus-infected & cancer cells
Phagocytes (neutrophils, macrophages)Engulf and destroy pathogens
Complement systemProteins that lyse (burst) bacteria
InterferonsAntiviral proteins released by infected cells

C. Adaptive Immunity β€” Details

Two branches:
ADAPTIVE IMMUNITY
β”œβ”€β”€ HUMORAL (B-cell mediated)
β”‚   β”œβ”€β”€ B lymphocytes β†’ plasma cells β†’ ANTIBODIES
β”‚   β”œβ”€β”€ Fights extracellular pathogens (bacteria, viruses in blood)
β”‚   └── Example: antibodies against Tetanus toxin
└── CELL-MEDIATED (T-cell mediated)
    β”œβ”€β”€ T lymphocytes (T-helper, T-cytotoxic)
    β”œβ”€β”€ Fights intracellular pathogens (viruses, TB, fungi)
    └── Example: killing of virus-infected cells by CD8+ T cells

D. Classification by How Immunity Is Acquired

ACQUIRED IMMUNITY
β”œβ”€β”€ ACTIVE (host makes own antibodies)
β”‚   β”œβ”€β”€ Natural Active β†’ infection/disease (e.g., chicken pox)
β”‚   └── Artificial Active β†’ VACCINES (e.g., MMR vaccine)
└── PASSIVE (ready-made antibodies given)
    β”œβ”€β”€ Natural Passive β†’ maternal antibodies via placenta/breast milk
    └── Artificial Passive β†’ antiserum/immunoglobulins (e.g., anti-rabies serum)
Mnemonic: NAPA β€” Natural Active, Passive Active β†’ think "NAPA" for the four types
FeatureActivePassive
Antibody sourceHost makes ownTransferred from outside
OnsetSlow (days-weeks)Immediate
DurationLong-lasting (years/life)Short (weeks-months)
MemoryYESNO
ExampleVaccine, natural infectionAnti-tetanus serum, breast milk

4. ANTIGEN AND ANTIBODY REACTION

What is an Antigen?

  • A substance (usually protein or polysaccharide) that the immune system recognizes as foreign
  • Has special sites called epitopes (antigenic determinants) β€” these are the parts the antibody binds to
  • Types:
    • T-dependent antigen β†’ needs T-helper cells to stimulate antibody production (most proteins)
    • T-independent antigen β†’ stimulates B cells directly (polysaccharides)

What is an Antibody (Immunoglobulin)?

  • A Y-shaped glycoprotein made by plasma cells (activated B cells)
  • Specifically binds to the antigen that triggered its production

Antigen-Antibody Reaction (Immunological Reaction)

Antigen enters body
      ↓
Recognized by B cells (with help from T-helper cells)
      ↓
B cells β†’ Plasma cells β†’ Antibodies produced
      ↓
Antibody binds to specific antigen (lock-and-key)
      ↓
Results in:
  β”œβ”€β”€ Neutralization (toxin/virus rendered harmless)
  β”œβ”€β”€ Opsonization (antigen coated for phagocytosis)
  β”œβ”€β”€ Complement activation (bacterial lysis)
  β”œβ”€β”€ Agglutination (clumping of antigens)
  └── Precipitation (soluble antigen made insoluble)

5. IMMUNOGLOBULINS: STRUCTURE, TYPES & PROPERTIES

Structure of an Antibody (IgG as model)

         Fab (Antigen-binding)    Fab
              β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”        β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”
              β”‚  VH+VL β”‚        β”‚  VH+VL β”‚    ← Variable regions (bind antigen)
              β””β”€β”€β”€β”€β”¬β”€β”€β”€β”˜        β””β”€β”€β”€β”€β”¬β”€β”€β”€β”˜
                   β”‚                β”‚
              ─────┴────────────────┴─────
              β”‚     HINGE REGION          β”‚    ← Flexible
              β”‚         CH2              β”‚
              β”‚         CH3              β”‚    ← Fc region (complement, receptor binding)
              β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
  • 2 Heavy chains (H) + 2 Light chains (L) linked by disulfide bonds
  • Each chain has a Variable region (V) β€” binds antigen (unique per antibody)
  • Each chain has a Constant region (C) β€” determines Ig class and effector function
  • Fab fragment = antigen-binding fragment (contains variable regions)
  • Fc fragment = crystallizable fragment (binds complement, macrophage receptors)
  • Paratope = part of antibody that binds to epitope

Five Classes of Immunoglobulins

Class% in serumStructureKey Properties
IgG75–80%MonomerMost abundant; crosses placenta (passive immunity to newborn); 4 subclasses (IgG1–4); secondary immune response; opsonization
IgA10–15%Dimer (secretory)Found in secretions: saliva, tears, breast milk, intestinal mucus; first defense at mucosal surfaces
IgM5–10%PentamerLargest Ig; first to appear in primary immune response; best at agglutination & complement activation; ABO blood group antibodies
IgETrace (<0.01%)MonomerAllergic reactions (binds mast cells, basophils); anti-parasitic immunity; involved in Type I hypersensitivity
IgD<1%MonomerB-cell surface receptor; function not fully known
Mnemonic: GAMED β€” IgG, IgA, IgM, IgE, IgD (in order of serum concentration)

Properties Summary Table

PropertyIgGIgAIgMIgEIgD
Crosses placentaβœ…βŒβŒβŒβŒ
In secretionsβŒβœ…βŒβŒβŒ
Complement fixationβœ…βŒβœ…βœ…βŒβŒ
Allergy/anaphylaxisβŒβŒβŒβœ…βŒ
Primary responseβŒβŒβœ…βŒβŒ

6. HYPERSENSITIVITY REACTIONS

Definition

  • An exaggerated or inappropriate immune response to an antigen (allergen) that causes tissue damage
  • Classified by Gell and Coombs (1963) into 4 types

Gell & Coombs Classification

HYPERSENSITIVITY
β”œβ”€β”€ Type I  β†’ Immediate / Anaphylactic (IgE-mediated)
β”œβ”€β”€ Type II β†’ Cytotoxic (IgG/IgM-mediated, cell destruction)
β”œβ”€β”€ Type III β†’ Immune Complex (IgG-mediated, complex deposition)
└── Type IV β†’ Delayed / Cell-mediated (T-cell mediated, NO antibody)
Mnemonic: ACID β€” Anaphylactic, Cytotoxic, Immune-complex, Delayed

TYPE I β€” Immediate Hypersensitivity (Anaphylactic)

Mediator: IgE
Time of onset: Within minutes (15–30 min)
Cells involved: Mast cells, basophils, eosinophils
Mechanism (Flowchart):
First exposure to allergen (e.g., peanut, penicillin, pollen)
      ↓
B cells stimulated β†’ IgE antibodies produced
      ↓
IgE binds to surface of MAST CELLS and BASOPHILS (sensitization)
      ↓
Second exposure to same allergen
      ↓
Allergen cross-links IgE on mast cells
      ↓
DEGRANULATION β†’ release of:
  β”œβ”€β”€ Histamine β†’ vasodilation, bronchoconstriction, itching
  β”œβ”€β”€ Leukotrienes β†’ prolonged bronchoconstriction
  β”œβ”€β”€ Prostaglandins β†’ inflammation
  └── Tryptase (marker of anaphylaxis)
      ↓
Clinical effects: urticaria, angioedema, bronchospasm, anaphylaxis
Examples:
  • Anaphylaxis (penicillin, bee sting)
  • Bronchial asthma
  • Allergic rhinitis (hay fever)
  • Urticaria (hives)
  • Food allergy (peanuts, shellfish)
Clinical Example:
A 22-year-old nursing student receives IV penicillin and within 10 minutes develops rash, swelling of throat, low BP, and difficulty breathing β†’ Anaphylactic shock = Type I hypersensitivity. Treatment: Adrenaline (epinephrine) 0.5 mg IM immediately.

TYPE II β€” Cytotoxic Hypersensitivity

Mediator: IgG or IgM
Time of onset: Minutes to hours
Target: Cell surface antigens (host cells destroyed)
Mechanism:
Antibody (IgG/IgM) binds to antigen on HOST CELL SURFACE
      ↓
Complement activated β†’ cell LYSIS (MAC attack)
OR
Phagocytosis of opsonized cells
OR
ADCC (Antibody Dependent Cell-mediated Cytotoxicity)
      ↓
HOST CELLS DESTROYED
Examples:
  • ABO transfusion reactions (wrong blood group given)
  • Hemolytic disease of newborn (Rh incompatibility β€” Rhβˆ’ve mother, Rh+ve baby)
  • Autoimmune hemolytic anemia
  • Goodpasture syndrome (antibodies to glomerular basement membrane)
  • Myasthenia gravis (antibodies against acetylcholine receptors)
  • Graves' disease (antibodies stimulate TSH receptors β†’ hyperthyroidism)

TYPE III β€” Immune Complex Hypersensitivity

Mediator: IgG (or IgM) antigen-antibody complexes
Time of onset: Hours (3–10 hours)
Target: Blood vessels, kidneys, joints (where complexes deposit)
Mechanism:
Antigen (soluble) + Antibody β†’ IMMUNE COMPLEX formed
      ↓
Immune complexes DEPOSIT in vessel walls, glomeruli, joints
      ↓
Complement activated
      ↓
Neutrophils attracted β†’ release lysosomal enzymes
      ↓
TISSUE INFLAMMATION and DAMAGE
Examples:
  • Serum sickness (after horse antiserum β€” old anti-tetanus)
  • Post-streptococcal glomerulonephritis
  • Systemic Lupus Erythematosus (SLE)
  • Rheumatoid arthritis
  • Arthus reaction (local immune complex reaction β€” repeat injection)
  • Farmer's lung (inhaled mold antigens)

TYPE IV β€” Delayed-Type Hypersensitivity (Cell-Mediated)

Mediator: T lymphocytes (NO antibody, NO complement)
Time of onset: 48–72 hours (delayed)
Cells: CD4+ T-helper cells (Th1), CD8+ cytotoxic T cells, macrophages
Mechanism:
First exposure to antigen β†’ T cells sensitized (memory T cells formed)
      ↓
Second exposure (24–72 hrs later)
      ↓
Memory T cells recognize antigen via APC (dendritic cells/macrophages)
      ↓
T cells activated β†’ release CYTOKINES (IFN-Ξ³, TNF, IL-2)
      ↓
Macrophages activated β†’ release inflammatory mediators
      ↓
TISSUE DESTRUCTION (granuloma formation)
Examples:
  • Tuberculin (Mantoux) test ← most important exam example
  • Contact dermatitis (nickel, latex, poison ivy)
  • Graft rejection (transplant rejection)
  • Granulomatous diseases (TB, leprosy, sarcoidosis)
Clinical Example:
A nurse reads a Mantoux test 72 hours after injection. She finds induration [hardness] of 15 mm β†’ Positive β†’ suggests TB infection = Type IV hypersensitivity
Hypersensitivity skin test reactions showing immediate (Type I) vs delayed (Type IV) responses

Comparison Table of All 4 Types

FeatureType IType IIType IIIType IV
MediatorIgEIgG/IgMIgG/IgM complexesT cells
OnsetMin (< 30 min)Min–hours3–10 hrs48–72 hrs
ComplementβŒβœ…βœ…βŒ
CellsMast cells, basophilsComplement, phagocytesNeutrophilsT cells, macrophages
Key exampleAnaphylaxisABO mismatchSLE, serum sicknessMantoux, contact dermatitis
Transferred bySerum (IgE)SerumSerumCells only

7. SEROLOGICAL TESTS (Antigen-Antibody Tests)

Serology [sero = serum] = laboratory tests that detect antibodies or antigens in blood serum

Classification of Serological Tests

A. Precipitation Tests

  • Antigen + Antibody β†’ insoluble precipitate forms
  • Examples:
    • Immunodiffusion (Ouchterlony test) β€” antigens/antibodies diffuse in gel; precipitation line forms where they meet
    • VDRL test (Venereal Disease Research Laboratory) β€” for syphilis screening; flocculation [clumping] reaction
    • RPR test (Rapid Plasma Reagin) β€” syphilis
    • C-reactive protein (CRP) test β€” detects inflammation

B. Agglutination Tests

  • Antigen (cell surface) + Antibody β†’ visible clumping
  • Examples:
    • Widal test β€” for typhoid fever (detects antibodies against Salmonella typhi)
    • ABO blood grouping β€” agglutination of RBCs
    • Coombs test (DCT/ICT) β€” hemolytic disease of newborn, autoimmune hemolytic anemia
    • ASO test (Anti-Streptolysin O) β€” detects recent streptococcal infection
    • RA Factor (Rheumatoid Factor) test β€” for rheumatoid arthritis

C. Complement Fixation Tests

  • If antigen + antibody present β†’ complement is "used up" (fixed) β†’ indicator system remains intact (no lysis)
  • Examples:
    • Wassermann test β€” syphilis (historical)
    • CFT for viral antibodies β€” measles, mumps

D. Neutralization Tests

  • Antibody neutralizes the biological activity of a toxin or virus
  • Examples:
    • ASO titre β€” neutralization of streptolysin O
    • Virus neutralization tests β€” check immunity to specific viruses

E. Immunofluorescence Tests

  • Antibodies labeled with fluorescent dye β†’ seen under fluorescence microscope
  • Examples:
    • IFAT (Indirect Fluorescent Antibody Test)
    • ANA test (Anti-Nuclear Antibody) β€” for SLE
    • TPHA test β€” for syphilis confirmation

F. Enzyme-Linked Tests (ELISA)

  • ELISA (Enzyme-Linked ImmunoSorbent Assay)
  • Most common and important modern test
  • Detects antibodies (IgG, IgM) or antigens
  • Used for:
    • HIV screening (ELISA for anti-HIV antibodies)
    • Hepatitis B & C
    • TORCH infections in pregnancy
    • COVID-19 antibody tests

G. Radioimmunoassay (RIA)

  • Uses radioactively labeled antigen or antibody
  • Very sensitive but requires radioactive material
  • Used for: hormone levels (insulin, TSH), HBsAg (Hepatitis B surface antigen)

H. Western Blot

  • Confirmatory test for HIV (after ELISA screening)
  • Separates viral proteins by electrophoresis β†’ detected by antibodies
  • Gold standard for HIV confirmation

Important Serological Tests Summary Table

TestDiseasePrinciple
Widal testTyphoidAgglutination
VDRL / RPRSyphilisPrecipitation/Flocculation
ASO titreStreptococcal infectionNeutralization/Agglutination
Coombs test (DCT/ICT)Hemolytic anemia, Rh incompatibilityAgglutination
ELISAHIV, Hepatitis, COVID-19Enzyme-linked
Western BlotHIV confirmationImmunoelectrophoresis
ANA testSLEImmunofluorescence
Mantoux/TuberculinTBDelayed hypersensitivity (Type IV)
RA FactorRheumatoid arthritisAgglutination

8. VACCINES: TYPES, CLASSIFICATION, STORAGE & COLD CHAIN

Definition

  • A vaccine is a biological preparation that provides active acquired immunity to a specific disease
  • It contains antigens (weakened/killed/toxoid/subunit) that stimulate an immune response without causing disease

Types / Classification of Vaccines

1. Live Attenuated [weakened] Vaccines

  • Contain weakened but living microorganisms
  • Give strong, long-lasting immunity (similar to natural infection)
  • Usually 1–2 doses sufficient
  • Contraindicated in immunocompromised patients (HIV, on steroids)
VaccineDisease
BCGTuberculosis
OPV (Oral Polio Vaccine)Poliomyelitis
MMRMeasles, Mumps, Rubella
Varicella vaccineChickenpox
Yellow Fever vaccineYellow fever
Rotavirus vaccineRotavirus diarrhea
Typhoid oral (Ty21a)Typhoid

2. Killed (Inactivated) Vaccines

  • Contain dead microorganisms β€” cannot cause disease
  • Safer, more stable
  • Require multiple doses + boosters (weaker immunity)
  • Safe in immunocompromised patients
VaccineDisease
IPV (Inactivated Polio Vaccine)Poliomyelitis
Pertussis (whole cell) in DPTWhooping cough
Rabies vaccine (HDCV)Rabies
Influenza (injectable)Influenza
Cholera vaccineCholera
Hepatitis A vaccineHepatitis A

3. Toxoid Vaccines

  • Made from inactivated bacterial toxins (the poison, not the bacteria)
  • Stimulate antibodies against toxin only
  • Very stable
VaccineDisease
DT / dT / TdDiphtheria, Tetanus
TT (Tetanus Toxoid)Tetanus

4. Subunit / Recombinant Vaccines

  • Contain only specific parts (proteins) of the pathogen
  • Very safe, no risk of infection
  • Hepatitis B vaccine (HBsAg protein) β€” recombinant DNA technology
  • Pertussis acellular (DTaP) β€” pertussis proteins only
  • HPV vaccine (Gardasil, Cervarix) β€” virus-like particles
  • Pneumococcal vaccine (PCV)
  • Meningococcal vaccine

5. Conjugate Vaccines

  • Polysaccharide antigen conjugated (joined) to a protein carrier
  • Makes polysaccharide antigens work in infants (T-cell dependent response)
  • Examples:
    • Hib vaccine (Haemophilus influenzae type b)
    • PCV (Pneumococcal Conjugate Vaccine)
    • MenACWY (Meningococcal conjugate vaccine)

6. mRNA Vaccines (Newer type)

  • Deliver instructions (mRNA) for cells to make viral protein β†’ immune response
  • Example: COVID-19 vaccines (Pfizer-BioNTech, Moderna)
  • No DNA alteration; mRNA quickly degraded

7. Combination Vaccines

  • Multiple vaccines in one injection
  • Reduces number of injections, increases compliance
VaccineDiseases covered
DPT (Diphtheria-Pertussis-Tetanus)Diphtheria, Whooping cough, Tetanus
MMRMeasles, Mumps, Rubella
MMRVMeasles, Mumps, Rubella, Varicella
Pentavalent vaccineDiphtheria, Tetanus, Pertussis, Hepatitis B, Hib
Hexavalent vaccine+ Polio

Vaccine Storage and Handling

Principles

  • Vaccines are biological products β€” destroyed by heat, freezing (some), and light
  • Must be stored at correct temperature throughout supply chain

Storage Temperatures

Vaccine CategoryStorage Temp
Freeze-sensitive (must NOT freeze)+2Β°C to +8Β°C (refrigerator)
Freeze-tolerant (can freeze)βˆ’15Β°C to βˆ’25Β°C (freezer)
VaccineStorageSensitivity
BCGFreezer (βˆ’15Β°C to βˆ’25Β°C)Sensitive to heat & light
OPVFreezer (βˆ’20Β°C)Very heat-sensitive; can store frozen
IPVRefrigerator (+2 to +8Β°C)Freeze-sensitive
DPTRefrigerator (+2 to +8Β°C)FREEZE-SENSITIVE β€” freezing destroys it
Hepatitis BRefrigerator (+2 to +8Β°C)FREEZE-SENSITIVE
TTRefrigerator (+2 to +8Β°C)FREEZE-SENSITIVE
MMRFreezer or refrigeratorSensitive to heat & light
MeaslesRefrigerator, protect from lightHeat & light-sensitive
PentavalentRefrigerator (+2 to +8Β°C)FREEZE-SENSITIVE
⚠️ Key exam point: Vaccines most sensitive to freezing: DPT, TT, Hepatitis B, IPV, Pentavalent
⚠️ Vaccines most sensitive to heat: OPV, BCG, Measles, MMR

Reconstituted Vaccines (mixed before use)

  • BCG, Measles, MMR must be used within 4–6 hours after reconstitution [mixing with diluent]
  • Discard unused reconstituted vaccine at end of session

Cold Chain

Definition

  • Cold chain = the system of transporting and storing vaccines at the correct temperature from manufacturer to patient

Importance

  • Maintains potency (effectiveness) of vaccines
  • Prevents vaccine wastage
  • Ensures immunization programs succeed

Cold Chain Equipment

VACCINE MANUFACTURER (βˆ’25Β°C to βˆ’15Β°C or +2 to +8Β°C)
      ↓
PRIMARY VACCINE STORE (National level) β€” Deep freezers + ILR
      ↓
REGIONAL / STATE VACCINE STORE β€” Deep freezers + ILR
      ↓
DISTRICT VACCINE STORE β€” ILR (Ice-Lined Refrigerator) + Deep freezers
      ↓
PHC (Primary Health Center) β€” ILR + Deep freezers
      ↓
SUBCENTRE / SESSION SITE β€” Vaccine carrier + cold packs
      ↓
PATIENT / COMMUNITY
Equipment Abbreviations:
  • ILR = Ice-Lined Refrigerator (insulated box, runs on electricity, stores +2 to +8Β°C)
  • Deep Freezer = stores at βˆ’15Β°C to βˆ’25Β°C (for OPV, BCG)
  • Vaccine carrier = insulated box with frozen ice packs β€” for transport to field
  • Cold box = large insulated box for transport between stores
  • Cold packs / Ice packs = keep vaccines cold in carrier

Cold Chain Monitoring Tools

ToolPurpose
VVM (Vaccine Vial Monitor)Sticker on vaccine vial β€” changes color if vaccine exposed to excess heat; tells if vaccine is unusable
ThermometerMeasures fridge/freezer temperature
Freeze indicator (FI)Detects if freeze-sensitive vaccine was frozen
Electronic data loggerContinuous temperature recording
Open Vial PolicyAllows reuse of unopened multi-dose vials at next session (except BCG, measles, yellow fever, VZV)

VVM Reading (Exam Important)

VVM (inner square inside outer circle)
β”œβ”€β”€ Inner square LIGHTER than outer circle β†’ USABLE βœ…
└── Inner square SAME or DARKER than outer circle β†’ DISCARD ❌

Nursing Responsibilities in Cold Chain

  • Check temperature daily (2 times/day: morning and evening) β€” record in temperature log
  • Never store food, blood, or other items in vaccine fridge
  • Never keep vaccines in door of refrigerator (temperature fluctuates)
  • Place ice packs at bottom of vaccine carrier before use
  • Check VVM before giving each vaccine
  • Report cold chain equipment failures immediately
  • Store vaccines according to FIFO (First In, First Out) principle
  • Keep extra ice packs in freezer always

9. IMMUNIZATION FOR VARIOUS DISEASES β€” NATIONAL IMMUNIZATION SCHEDULE (India)

Universal Immunization Programme (UIP)

  • Started in India in 1985 (expanded from EPI started 1978)
  • Mission Indradhanush launched 2014 β€” aimed to increase coverage to 90%+ children
  • Target: Pregnant women + children 0–5 years

Immunization Schedule (India β€” Current UIP)

AgeVaccineRouteDoseSite
Birth (0–24 hrs)OPV-0 (birth dose)Oral2 dropsMouth
BCGIntradermal0.05 ml (<1 yr), 0.1 ml (>1 yr)Left upper arm
Hepatitis B (birth dose)IM0.5 mlAnterolateral thigh (right)
6 weeks (1.5 months)OPV-1Oral2 dropsMouth
Pentavalent-1 (DPT+HepB+Hib)IM0.5 mlAnterolateral thigh (left)
Rotavirus-1Oral5 dropsMouth
PCV-1 (Pneumococcal)IM0.5 mlAnterolateral thigh (right)
fIPV-1 (Fractional IPV)Intradermal0.1 mlRight anterolateral thigh
10 weeks (2.5 months)OPV-2Oral2 drops
Pentavalent-2IM0.5 ml
Rotavirus-2Oral5 drops
14 weeks (3.5 months)OPV-3Oral2 drops
Pentavalent-3IM0.5 ml
Rotavirus-3Oral5 drops
PCV-2IM0.5 ml
fIPV-2Intradermal0.1 ml
9–12 monthsMeasles-Rubella (MR)-1Subcutaneous0.5 mlRight upper arm
PCV BoosterIM0.5 ml
Vitamin A (1st dose)Oral1 lakh IU
16–24 monthsDPT Booster-1IM0.5 mlAnterolateral thigh
OPV BoosterOral2 drops
MR-2Subcutaneous0.5 mlRight upper arm
Vitamin A (every 6 months till 5 yrs)Oral2 lakh IU
5–6 yearsDPT Booster-2IM0.5 mlUpper arm
10 years & 16 yearsTd (Tetanus + adult diphtheria)IM0.5 mlUpper arm

Vaccines for Pregnant Women

VaccineSchedulePurpose
TT/Td-1As early as possible in pregnancySensitization dose
TT/Td-24 weeks after TT-1Boosts immunity
TT BoosterIf received TT in last 3 yearsSingle booster dose
Protection conferred: Prevents neonatal tetanus (tetanus in newborn) and maternal tetanus

Other Important Vaccines (Optional/Special Situations)

VaccineFor WhomSchedule
Typhoid vaccineAge 2 yrs+; endemic areas, travellersOral (Ty21a): 3 doses; IM (Vi): 1 dose; booster every 3 years
Hepatitis A vaccineAge 1 yr+; not in UIP2 doses: 0 and 6–12 months
Varicella (Chickenpox)12 months+; 2 doses0 and 3 months
HPV vaccineGirls 9–14 yrs (cervical cancer prevention)2 doses: 0 and 6 months
MeningococcalHigh-risk, Hajj pilgrimsSingle dose
Yellow FeverTravellers to endemic areas (Africa, S. America)1 dose; life-long protection
Rabies (post-exposure)After animal biteDays 0, 3, 7, 14, 28 (IM)
Japanese Encephalitis (JE)Endemic districts in India2 doses at 9 months and 16–24 months
InfluenzaHealthcare workers, elderly, high-riskAnnual dose
Pneumococcal (PPSV23)Adults >65 yrs, immunocompromised1–2 doses

10. NURSING CARE IN IMMUNIZATION

Pre-vaccination Nursing Responsibilities

  • Take detailed history: previous vaccinations, allergies, current illness
  • Contraindications to check:
    • Acute febrile illness β†’ postpone vaccine
    • Anaphylaxis to previous dose β†’ contraindicated
    • Live vaccines in immunocompromised patients
    • Encephalopathy within 7 days of DPT β†’ no more DPT
  • Inform parents about the vaccine, disease it prevents, and possible side effects (consent)
  • Check VVM on each vaccine vial
  • Check expiry date
  • Prepare correct dose and reconstitute if needed
  • Check cold chain maintenance

During Vaccination

  • Use correct route (IM, SC, intradermal, oral)
  • Use correct site as per age
  • Use proper injection technique (no air bubbles for injections)
  • Observe strict aseptic technique
  • Dispose of needles safely (no recapping β€” sharps container)
  • Reconstituted vaccine: shake well before use

Post-vaccination Nursing Responsibilities

  • Observe patient for 30 minutes for anaphylaxis (especially after first dose)
  • Anaphylaxis kit ready: adrenaline, antihistamine, corticosteroids, IV fluids
  • Document: vaccine name, dose, batch number, expiry, site, date
  • Inform parents about normal post-vaccination reactions
  • Advice for common side effects:
    • Fever β†’ paracetamol, tepid sponging
    • Local swelling/redness β†’ cold compress, reassurance
    • BCG ulcer/scar β†’ normal, no treatment needed
    • OPV: sore mouth β†’ very rare; reassure

AEFI (Adverse Events Following Immunization)

  • Any untoward medical event that follows immunization
  • Types:
    1. Vaccine-related (e.g., VAPP β€” vaccine-associated paralytic polio from OPV)
    2. Injection-related (abscess, nerve damage)
    3. Immunization error (wrong dose, wrong route)
    4. Coincidental (not caused by vaccine)
  • Must be reported to health authorities within 24 hours for serious AEFI

11. SIGNS & SYMPTOMS β€” ANAPHYLAXIS (most important acute immune emergency)

Anaphylaxis = severe, life-threatening Type I hypersensitivity reaction

Mnemonic: "ABCDEF" for Anaphylaxis features

  • Airway obstruction (throat swelling, stridor)
  • Breathing difficulty (bronchospasm, wheeze)
  • Cardiovascular collapse (hypotension, tachycardia)
  • Dermal signs (urticaria, angioedema, flushing, itching)
  • Excretion (nausea, vomiting, diarrhea)
  • Feeling of doom (anxiety, confusion, loss of consciousness)

Anaphylaxis Management (Nursing Emergency)

RECOGNIZE: Symptoms within minutes of exposure
      ↓
CALL FOR HELP / CODE BLUE
      ↓
LAY PATIENT FLAT β€” raise legs (unless breathing difficulty β†’ semi-recumbent)
      ↓
ADRENALINE (EPINEPHRINE): 0.5 mg IM (1:1000) in outer thigh β€” FIRST DRUG
      ↓
Oβ‚‚ therapy (high flow, 10–15 L/min via mask)
      ↓
IV access β€” normal saline bolus (500 ml–1 L)
      ↓
ANTIHISTAMINE: Chlorphenamine 10 mg IV/IM
      ↓
HYDROCORTISONE: 200 mg IV (prevents biphasic reaction)
      ↓
MONITOR: BP, pulse, SpOβ‚‚ every 5 min
      ↓
OBSERVE minimum 6 hours (risk of biphasic reaction β€” second wave)

12. DIAGNOSIS / INVESTIGATIONS FOR IMMUNE DISORDERS

InvestigationPurpose
CBC with differentialWBC count; lymphocytopenia β†’ immunodeficiency
Serum immunoglobulins (IgG, IgA, IgM, IgE)Low IgG β†’ hypogammaglobulinemia; high IgE β†’ allergy
Skin prick test / intradermal testDetects Type I hypersensitivity (allergy testing)
Patch testDetects Type IV (contact dermatitis)
Mantoux testDetects TB (Type IV hypersensitivity)
ELISAHIV, Hepatitis, autoantibodies
ANA (Anti-Nuclear Antibody)SLE
Complement levels (C3, C4)Low in SLE, immune complex diseases
Flow cytometryCD4/CD8 count (HIV staging)
Western BlotHIV confirmation
Coombs testHemolytic anemia

13. COMPLICATIONS

Complications of Immune Disorders

ConditionComplication
AnaphylaxisDeath from cardiovascular/respiratory collapse
Hypersensitivity reactionsOrgan damage, chronic inflammation
SLELupus nephritis, pericarditis, neuropsychiatric lupus
Rheumatoid arthritisJoint deformity, disability

Complications of Vaccines

VaccineComplication
OPVVAPP (Vaccine-Associated Paralytic Polio) β€” rare, 1/750,000
BCGBCG-itis (disseminated BCG in immunocompromised)
DPTFebrile seizures, encephalopathy (rare)
MMRFebrile seizures, thrombocytopenia (rare)

Complications of Cold Chain Failure

  • Vaccine rendered ineffective (loss of potency)
  • Vaccine-preventable disease outbreaks
  • False sense of security in immunized population

14. PREVENTION

  • Maintain cold chain rigorously
  • Educate communities about immunization benefits
  • Ensure complete immunization schedule is followed (full doses, correct timing)
  • Monitor for AEFI and report
  • Conduct immunization camps in remote areas (Mission Indradhanush)
  • Administer vaccines by trained healthcare personnel only
  • Maintain herd immunity [when enough population is immune, disease cannot spread]

15. QUICK REVISION POINTS ⚑

  • Innate = non-specific, fast, no memory | Adaptive = specific, slower, has memory
  • Active immunity = makes own antibodies (long lasting) | Passive = ready-made antibodies (short lasting)
  • IgG = most abundant, crosses placenta | IgA = secretions/mucosa | IgM = first in primary response | IgE = allergy/anaphylaxis
  • Type I = IgE, mast cells, immediate β†’ anaphylaxis, asthma, urticaria
  • Type II = IgG/IgM, cell destruction β†’ ABO mismatch, hemolytic disease of newborn
  • Type III = immune complexes β†’ SLE, serum sickness, post-strep GN
  • Type IV = T cells, 48–72 hrs β†’ Mantoux test, contact dermatitis, graft rejection
  • VDRL = syphilis | Widal = typhoid | ELISA = HIV, Hep B | Western Blot = HIV confirmation
  • VVM inner square lighter than outer = vaccine usable βœ… | Same/darker = discard ❌
  • DPT, TT, HepB = freeze-sensitive | OPV, BCG = heat-sensitive
  • First drug in anaphylaxis = ADRENALINE (Epinephrine) 0.5 mg IM
  • BCG given at birth (0–24 hrs) | OPV birth dose also at birth
  • Pentavalent = 5 antigens in 1 vaccine: DPT + HepB + Hib
  • Observe 30 minutes post-vaccination for anaphylaxis

16. MICROBIOLOGY β€” RELEVANT POINTS

Immunological Aspects of Microbiology

Bacterial vaccines: Made from killed bacteria (cholera), toxoids (DPT), or live attenuated (BCG)
Viral vaccines: Live attenuated (OPV, MMR, BCG) or killed (IPV, rabies)
Serological diagnosis of infections:
  • Typhoid: Widal test (H & O agglutinins β‰₯ 1:160 = significant)
  • Syphilis: VDRL (screening) β†’ TPHA or FTA-ABS (confirmation)
  • HIV: ELISA (screening) β†’ Western blot (confirmation)
  • Hepatitis B: HBsAg (surface antigen) = active infection; Anti-HBs = immunity

17. PHARMACOLOGY β€” RELEVANT DRUGS

Drugs Used in Anaphylaxis

DrugClassMechanismDoseNursing Points
Epinephrine (Adrenaline)Alpha + Beta agonistBronchodilates, raises BP, reverses vasodilation0.5 mg IM (1:1000)FIRST DRUG; IM in outer thigh; can repeat after 5 min
Chlorphenamine (Piriton)H1-antihistamineBlocks histamine H1 receptors β†’ reduces itch, urticaria10 mg IV/IMCauses drowsiness; do not drive
HydrocortisoneCorticosteroidAnti-inflammatory; prevents late/biphasic reaction200 mg IVNot first-line; supports long-term control
SalbutamolBeta-2 agonistBronchodilationNebulizedFor persistent bronchospasm

Drugs Used in Hypersensitivity (Allergy)

DrugUse
Cetirizine, Loratadine (2nd gen antihistamines)Allergic rhinitis, urticaria β€” less sedating
Montelukast (Leukotriene receptor antagonist)Asthma, allergic rhinitis
Prednisolone (oral corticosteroid)Severe allergy, autoimmune disease
Omalizumab (Anti-IgE antibody)Severe allergic asthma β€” reduces free IgE

18. CLINICAL EXAMPLES

Case 1: Anaphylaxis

A 30-year-old woman receives IV amoxicillin for UTI. Within 5 minutes she develops generalized urticaria, throat tightness, wheezing, and BP drops to 70/40 mmHg.
Diagnosis: Anaphylaxis β€” Type I hypersensitivity to penicillin
Immediate nursing action: Stop drug β†’ Call help β†’ Lay flat β†’ Adrenaline 0.5 mg IM β†’ Oβ‚‚ β†’ IV fluids

Case 2: Mantoux (Tuberculin) Test

A 20-year-old nurse undergoes a Mantoux test. At 72 hours, she has induration [raised hardness] of 18 mm.
Interpretation: Positive (β‰₯10 mm in healthcare workers = significant)
Type: Type IV (Delayed) Hypersensitivity
Next step: Chest X-ray + sputum AFB smear to rule out active TB

πŸ“ EXAMINATION QUESTIONS

LONG QUESTIONS (10–15 marks each)

  1. Classify immunity. Describe innate and adaptive immunity in detail with differences.
  2. Describe the structure and classes of immunoglobulins. Add a note on their properties and functions.
  3. Classify and explain hypersensitivity reactions with pathophysiology, clinical examples, and nursing management.
  4. Describe the cold chain system in immunization. What are cold chain equipment, monitoring tools, and nursing responsibilities in maintaining cold chain?
  5. Write the national immunization schedule for children under 5 years. Add a note on vaccines for pregnant women and AEFI.

SHORT QUESTIONS (5 marks each)

  1. Write a note on Type I (anaphylactic) hypersensitivity β€” mechanism and management.
  2. Differentiate between active and passive immunity with examples.
  3. Explain the Gell and Coombs classification of hypersensitivity reactions.
  4. What is the Vaccine Vial Monitor (VVM)? How is it used?
  5. Write a short note on serological tests used in clinical practice.

VERY SHORT QUESTIONS (2 marks each)

  1. Define antigen and antibody.
  2. What is an epitope?
  3. Which immunoglobulin crosses the placenta?
  4. Name the immunoglobulin involved in allergic reactions.
  5. What is the first drug given in anaphylaxis?
  6. What is herd immunity?
  7. Define cold chain.
  8. What is AEFI? Give one example.
  9. State two freeze-sensitive vaccines.
  10. What is the route and dose of BCG vaccine?

MULTIPLE CHOICE QUESTIONS (MCQs)

1. Which immunoglobulin is the FIRST to appear in a primary immune response?
a) IgG b) IgA c) IgM βœ… d) IgE
2. Type IV hypersensitivity is mediated by:
a) IgE b) IgG c) Complement d) T lymphocytes βœ…
3. The Mantoux test is an example of which type of hypersensitivity?
a) Type I b) Type II c) Type III d) Type IV βœ…
4. Which vaccine is most sensitive to HEAT?
a) DPT b) TT c) OPV βœ… d) Hepatitis B
5. Anaphylaxis is treated FIRST with:
a) Hydrocortisone b) Chlorphenamine c) Adrenaline βœ… d) Salbutamol
6. IgA is mainly found in:
a) Blood only b) Secretions (saliva, tears, breast milk) βœ… c) Lymph nodes d) Bone marrow
7. Which vaccine is given INTRADERMALLY?
a) DPT b) Hepatitis B c) BCG βœ… d) OPV
8. VVM inner square is DARKER than outer circle. The nurse should:
a) Use the vaccine b) Keep in freezer c) Discard the vaccine βœ… d) Warm the vaccine
9. Serum sickness is an example of which hypersensitivity?
a) Type I b) Type II c) Type III βœ… d) Type IV
10. The pentavalent vaccine protects against how many diseases?
a) 3 b) 4 c) 5 βœ… d) 6
(Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib)

ANSWER KEY

QAnswer
MCQ 1c β€” IgM
MCQ 2d β€” T lymphocytes
MCQ 3d β€” Type IV
MCQ 4c β€” OPV
MCQ 5c β€” Adrenaline
MCQ 6b β€” Secretions
MCQ 7c β€” BCG
MCQ 8c β€” Discard vaccine
MCQ 9c β€” Type III
MCQ 10c β€” 5 diseases

πŸ“„ FINAL 1-PAGE QUICK REVISION SUMMARY

╔══════════════════════════════════════════════════════════════════════════╗
β•‘          IMMUNITY, HYPERSENSITIVITY & IMMUNIZATION β€” QUICK REVISION      β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ IMMUNITY                                                                 β•‘
β•‘ Innate = fast, non-specific, no memory (skin, phagocytes, NK cells)      β•‘
║ Adaptive = slow, specific, has memory (B cells→antibodies; T cells)      ║
β•‘ Active (own antibody, long-lasting) vs Passive (ready-made, short)       β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ IMMUNOGLOBULINS (GAMED)                                                  β•‘
β•‘ IgG = most abundant, crosses placenta                                    β•‘
β•‘ IgA = secretions (saliva, milk, tears)                                   β•‘
β•‘ IgM = first in primary response, pentamer                                β•‘
β•‘ IgE = allergy/anaphylaxis (binds mast cells)                             β•‘
β•‘ IgD = B-cell surface receptor                                            β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ HYPERSENSITIVITY (ACID)                                                  β•‘
β•‘ Type I = IgE + mast cells = Anaphylaxis (<30 min) [Penicillin, pollen]  β•‘
β•‘ Type II = IgG/IgM + complement = Cytotoxic [ABO mismatch, MG]          β•‘
β•‘ Type III = Immune complexes = Tissue damage [SLE, serum sickness]       β•‘
β•‘ Type IV = T cells = Delayed 48-72 hrs [Mantoux, contact dermatitis]     β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ SEROLOGICAL TESTS                                                        β•‘
β•‘ Widal=Typhoid | VDRL=Syphilis | ELISA=HIV/HepB | Western Blot=HIV confirmβ•‘
β•‘ Mantoux = TB | ANA = SLE | Coombs = Hemolytic anemia                    β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ VACCINES                                                                 β•‘
β•‘ Live attenuated: BCG, OPV, MMR, Measles (strong, long immunity)         β•‘
β•‘ Killed: IPV, DPT-whole cell, Hepatitis A (multiple doses needed)        β•‘
β•‘ Toxoid: DPT, TT (against bacterial toxin)                               β•‘
β•‘ Subunit/Recombinant: HepB, HPV, Pneumococcal, Acellular Pertussis       β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ COLD CHAIN IMPORTANT FACTS                                               β•‘
β•‘ Heat-sensitive: OPV, BCG, Measles, MMR (store in freezer)               β•‘
β•‘ Freeze-sensitive: DPT, TT, HepB, IPV, Pentavalent (store +2 to +8Β°C)  β•‘
β•‘ VVM: inner square LIGHTER = usable βœ… | SAME/DARKER = discard ❌        β•‘
β•‘ Reconstituted BCG/Measles/MMR: use within 4-6 hours                    β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ NATIONAL IMMUNIZATION SCHEDULE KEY POINTS                                β•‘
β•‘ Birth: BCG (ID), OPV-0 (oral), HepB-0 (IM)                             β•‘
β•‘ 6, 10, 14 weeks: OPV, Pentavalent, Rotavirus (+PCV & fIPV at 6 & 14 wk)β•‘
β•‘ 9-12 months: MR-1, PCV booster, Vit A                                   β•‘
β•‘ 16-24 months: DPT B1, OPV B, MR-2, Vit A                               β•‘
β•‘ 5-6 years: DPT Booster-2 | 10 & 16 years: Td                           β•‘
β•‘ Pregnant women: TT/Td-1 + TT/Td-2 (4 weeks apart) β†’ neonatal tetanus   β•‘
╠══════════════════════════════════════════════════════════════════════════╣
β•‘ ANAPHYLAXIS MANAGEMENT                                                   β•‘
β•‘ FIRST β†’ ADRENALINE 0.5 mg IM (1:1000) outer thigh                      β•‘
β•‘ Then: Oβ‚‚, IV fluids, Chlorphenamine, Hydrocortisone                     β•‘
β•‘ Observe 30 min post-vaccination; 6 hrs after anaphylaxis (biphasic)     β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•

Sources: Cellular and Molecular Immunology (Abbas & Lichtman); Janeway's Immunobiology 10e; Robbins & Kumar Basic Pathology; Roitt's Essential Immunology; WHO Immunization Handbook; India UIP Schedule (2024)
This is a shared conversation. Sign in to Orris to start your own chat.